360 High-Risk Vulnerability Immunization Tool V2.0 vs HarfangLab Cybersecurity Solutions: Side-by-Side Comparison (2026)
Features, pricing, ratings, and pros and cons, compared head to head.
360 High-Risk Vulnerability Immunization Tool V2.0 is a commercial endpoint protection platform tool by 360 Security Group (Qihoo 360). HarfangLab Cybersecurity Solutions is a commercial endpoint detection and response tool by HarfangLab. Compare features, ratings, integrations, and community reviews side by side to find the best endpoint protection platform fit for your security stack. Independent and vendor-neutral: our scores and rankings are earned, never bought — sponsored placement is always labeled.
CST VerdictShort answer
Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats. Mid-market teams managing mixed Windows and Linux infrastructure will get real value from HarfangLab Cybersecurity Solutions because its Rust-based agent actually consumes half the resources of typical EDR platforms while maintaining detection parity. The vendor's focus on NIST DE.CM and RS.AN means you get continuous monitoring and solid forensics support, though incident response automation lags behind competitors like CrowdStrike. Skip this if you need air-gapped deployment as your primary use case; the platform supports it, but it's not where the product matured first.
Based on our analysis of NIST CSF 2.0 coverage, core features, integrations, company size fit, here is our conclusion:
360 High-Risk Vulnerability Immunization Tool V2.0
Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats.
HarfangLab Cybersecurity Solutions
Mid-market teams managing mixed Windows and Linux infrastructure will get real value from HarfangLab Cybersecurity Solutions because its Rust-based agent actually consumes half the resources of typical EDR platforms while maintaining detection parity. The vendor's focus on NIST DE.CM and RS.AN means you get continuous monitoring and solid forensics support, though incident response automation lags behind competitors like CrowdStrike. Skip this if you need air-gapped deployment as your primary use case; the platform supports it, but it's not where the product matured first.
Data verified Aug 2026
View 360 High-Risk Vulnerability Immunization Tool V2.0All Endpoint Protection PlatformAlternativesStacksMarket MapExplore All Tools
Sponsored
360 High-Risk Vulnerability Immunization Tool V2.0
Tool that immunizes Windows systems against critical vulnerabilities
HarfangLab Cybersecurity Solutions
EDR platform with EPP capabilities for endpoint threat detection and response
Side-by-Side Comparison
Feature
360 High-Risk Vulnerability Immunization Tool V2.0
HarfangLab Cybersecurity Solutions
Pricing Model
Commercial
Commercial
Category
Endpoint Protection Platform
Endpoint Detection and Response
Verified Vendor
Deployment & Fit
Deployment Type
On-Premises
Hybrid
Company Size Fit
Startup, SMB, Mid-Market, Enterprise
SMB, Mid-Market, Enterprise
Company Information
Company
360 Security Group (Qihoo 360)
HarfangLab
Headquarters
Use Cases & Capabilities
Windows Security
Remote Desktop
CVE
Zero Day
Patch Management
System Security
MITRE Attack
Sigma
Linux
YARA
NIST CSF 2.0 Coverage
NIST CSF 2.0 Mapping
Access NIST CSF 2.0 data from thousands of security products via MCP to assess your stack coverage.
Access via MCPCore Features
- Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182)
- MS17-010 SMB vulnerability protection against ransomware
- Meltdown CPU vulnerability mitigation
- Spectre CPU vulnerability mitigation
- Total Meltdown vulnerability protection for Windows 7 x64
- ASUS Live Update supply chain attack protection
- WinRAR UNACEV2.dll vulnerability immunization
- IE/VBScript CVE-2018-8174 zero-day protection
- Endpoint detection and response for Windows and Linux
- Endpoint protection platform (EPP) capabilities
- YARA and Sigma rule-based threat detection
- File integrity monitoring
- DLL sideloading attack protection
- EDR freeze attack protection
- Attack surface management with vulnerability management
- Shadow IT monitoring
Integrations
No integrations listed
Sekoia.io
Community
Community Votes
0
0
Bookmarks
User Reviews
No reviews yet
No reviews yet
Need help choosing?
Explore more tools in this category or create a security stack with your selections.
360 High-Risk Vulnerability Immunization Tool V2.0 vs HarfangLab Cybersecurity Solutions FAQ
Common questions about comparing 360 High-Risk Vulnerability Immunization Tool V2.0 vs HarfangLab Cybersecurity Solutions for your endpoint protection platform needs.
360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..
HarfangLab Cybersecurity Solutions: EDR platform with EPP capabilities for endpoint threat detection and response. built by HarfangLab. Core capabilities include Endpoint detection and response for Windows and Linux, Endpoint protection platform (EPP) capabilities, YARA and Sigma rule-based threat detection..
Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.
360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. HarfangLab Cybersecurity Solutions differentiates with Endpoint detection and response for Windows and Linux, Endpoint protection platform (EPP) capabilities, YARA and Sigma rule-based threat detection.
360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). HarfangLab Cybersecurity Solutions is developed by HarfangLab. The vendor behind a product decides its roadmap, support, and longevity, so check each company's profile before you commit.
360 High-Risk Vulnerability Immunization Tool V2.0 and HarfangLab Cybersecurity Solutions serve similar Endpoint Protection Platform use cases: both cover Windows Security. Review the feature comparison above to determine which fits your requirements.
Have more questions? Browse our categories or search for specific tools.
Related Comparisons
360 High-Risk Vulnerability Immunization Tool V2.0 vs Abatis System360 High-Risk Vulnerability Immunization Tool V2.0 vs Absolute Ransomware Response360 High-Risk Vulnerability Immunization Tool V2.0 vs Absolute ResilienceHarfangLab Cybersecurity Solutions vs Abatis SystemHarfangLab Cybersecurity Solutions vs Absolute Ransomware ResponseHarfangLab Cybersecurity Solutions vs Absolute Resilience
